Trial intelligence / Profile preview

Curcumin in cancer cachexic anorexia

TCTR20220521003Phase 2Completed

Sponsor
Phramongkutklao Hospital
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of curcumin in cancer anorexia-cachexia syndrome (CACS), anorexia nervosa (AN), sponsored by Phramongkutklao Hospital. Started Oct 2020; status: completed.

02

Drugs

curcumin
03

Conditions

cancer anorexia-cachexia syndrome (CACS)anorexia nervosa (AN)

Beyond the preview

Go deeper on TCTR20220521003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220521003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call